133 – Emerging Technologies in Analytical Testing (S9E13)

All right, welcome to the deep dive, everybody.
Today we're going to be diving into something
really critical and really exciting, and that
is the world of pharmaceutical quality control.
We're talking about the cutting edge stuff. You
know, for a long time we've relied on those tried
and true methods to make sure that our medications
are safe, that they work like they're supposed
to. But now, get this, there's this whole wave
of innovation coming at us with new analytical
technologies. I mean, it's like a tsunami, and
they could totally revolutionize how we look
at quality control. in this field. Yeah, you
know, what's really grabbing my attention with
all this is how these advancements have the potential
to really tackle some of the big challenges we've
been wrestling with for ages. Exactly. Like,
think about it. What if we could analyze these
drugs way faster, you know, at a fraction of
the cost? And even in places we never even thought
possible before. Right. I mean, that's what these
new technologies are starting to make a reality.
That's huge, right? Imagine a world where we're
not waiting forever for new meds to come out
because quality control is so streamlined. Or
think about the cost of medicine coming down.
That could mean more people can actually afford
the treatments they need. Exactly. And then there's
this whole idea of being able to do these quality
checks anywhere. I mean, that opens up some crazy
possibilities. So to really wrap our heads around
all of this, we've pulled together a bunch of
research, you know, stuff on drug development,
these super advanced analytical methods like
mass spectrometry, the whole regulatory scene,
which is obviously a big deal. And of course,
how these drugs are actually made. That's right.
And what we're aiming to do today is to sort
of sift through all this info, pull out the real
gems. We want to understand how all these tools
like we're talking microfluidics, ultra high
resolution mass spectrometry, portable spectroscopy.
And then, of course, you know. the AI thing,
machine learning. How are these things going
to totally revolutionize the future of pharmaceutical
quality control? It's like we're standing at
the edge of a whole new era. I completely agree.
So let's jump right in. First up, we got to talk
about microfluidics. When I hear that word, I
picture these teeny tiny labs, like almost microscopic
on a chip. Is that even close to reality? And
what does that kind of miniaturization mean for
pharmaceutical QC? Oh, you're right on the money
there. That's the essence of it. Microfluidics
gives us this amazing ability to run these complex
tests, you know, the kind we need for quality
control, but on a super small scale. And it's
not just about making things tiny. I mean, that's
cool and all. But the real game changer is the
potential for making everything way more efficient.
Like imagine walking into a QC lab and seeing
that they've slashed the amount of reagents they
need for a crucial test by like 90%. That's a
huge cost saving right there. And that frees
a budget for other important stuff like research
into new drugs. And because we're talking teeny
tiny volumes here, things happen a lot faster
too. Reactions just zip along. And that means
we can automate a lot of the steps with much
less hassle. Now, it's true that our sources
don't give us a ton of examples of this tech
being used everywhere in pharmaceutical QC just
yet, but Come on, we can see where it's heading.
Look at how successful it's been in in vitro
studies and high throughput screening. Yeah.
Those are areas where speed and efficiency are
king. And that's exactly what microfluidics delivers.
So maybe we won't see microfluidic chips replacing
entire labs right this second. But the idea of
doing more with less and doing it way faster,
that seems like a perfect fit for pharmaceutical
analysis. It's like we're taking this huge, powerful
lab and shrinking it down to the size of you
know, a postage stamp. You got it. And this whole
miniaturization thing, it's not just about saving
money on those reagents. It's also about running
tons of tests simultaneously. Like you can really
ramp up your throughput and generate data at
lightning speed. OK, all right. So that's microfluidics.
Super cool stuff. Next, we got to talk about
ultra high resolution mass spectrometry. Now.
That ultra high, that's got to be more than just
a fancy marketing term, right? I mean, what does
that level of detail really get you in pharmaceutical
analysis? Oh, it's definitely not just a buzzword.
It's the real deal. Yeah. We're talking about
being able to tell the difference between molecules
that are almost identical in mass. Like, imagine
being able to tell apart identical twins just
by looking at one single hair follicle. Wow.
In pharmaceutical QC, this level of precision
is crucial for pinpointing and measuring even
the tiniest impurities that could be harmful,
but that older methods might completely miss.
You know, one of our sources, the one on ADME
enabling technologies, it really stresses how
critical this technique is for accurately identifying
drug metabolites. Those are basically the compounds
that your body breaks the drug down into. And
of course, knowing exactly what those metabolites
are, whether any of them could be dangerous,
well, that's absolutely essential. Yeah. For
sure. So it's not just about knowing what the
main drug is. It's about getting this super detailed
fingerprint of everything else that might be
lurking in there, even in tiny amounts, and understanding
what those byproducts might do. Right. The Handbook
of Isolation and Characterization of Impurities,
that one goes even deeper. It points out that
this ultra -high resolution mass spectrometry
lets us analyze all sorts of complicated compounds,
even the ones that don't evaporate easily. And
it can break them down into these characteristic
fragments. They call it Collisional Activation
Spectra. It's like gently bumping. the identified
molecule into other molecules so it breaks apart
into smaller, more recognizable pieces. Kind
of like if you had to figure out what an object
was just by looking at the pieces after it shattered.
That kind of detailed structural information
is pure gold when it comes to making absolutely
sure we know what those impurities are and that
they're within those super strict regulatory
limits. So it sounds like it's not just for routine
checks, but also when something unexpected pops
up or if you're dealing with a brand new drug
molecule that's really complex. Exactly. Having
that level of detail gives you way more confidence
in the purity and the overall quality of the
drug. OK. Now, portable spectroscopy. This one
sounds like it could really change the game in
terms of where we can do quality analysis and
how quickly we can do it. So what's the big deal
here? What's all the buzz about? The core idea
is to take quality testing out of those central
labs and bring it to where the action is. Think
about it, running quick tests on raw materials
right when they show up at a manufacturing plant.
Or imagine monitoring those critical parameters
during production, like in real time. Now, it's
true that our sources don't give us a ton of
specifics about how portable spectroscopy is
being used for pharmaceutical QC right now, at
least not in the exact scenarios, but there's
this huge demand for faster, more efficient analysis,
and that's only getting bigger, especially when
you factor in things like dissolution rates and
bioavailability. That's how quickly the drug
dissolves and gets absorbed by the body. And
of course, that makes perfect sense. You need
reliable, accurate tools that you can take anywhere.
Right, of course. So maybe doctors aren't carrying
around these handheld spectrometers to check
meds in their offices just yet, but being able
to get those quick on -the -spot answers about
the quality of a drug at any point in its life
cycle, that could really smooth things out and
even maybe improve how secure the supply chain
is. Absolutely. And of course, the big thing
is making sure that these portable devices are
just as accurate and reliable as those big fancy
lab instruments. validating them and making sure
they're tough enough for use out in the field,
that's crucial. But you can't deny the potential
to cut down on delays and make quality checks
way more accessible. Right. OK. So last but certainly
not least, we got to talk about machine learning,
AI. Everybody's talking about it. So how can
algorithms and all that data crunching help us
make sure our drugs are top notch? Well, this
is where we can really put those mountains of
data that we're collecting throughout the entire
drug life cycle to good use. We've got a source
here, Artificial Intelligence in Drug Development,
and it talks about how AI is already shaking
things up in healthcare in general. You know,
it can analyze tons of complex biological data,
make things more efficient. That's happening
in diagnostics, you know, all sorts of areas.
And guess what? Those same principles, we can
apply them to QC. Yeah. Okay. Imagine. You know
these AI algorithms going through massive amounts
of QC data from different manufacturing batches
They're not just looking for those obvious red
flags those out -of -spec results They're digging
deeper finding subtle patterns connections that
a human analyst might completely miss They can
even predict potential quality issues before
they even happen. Maybe there's a slight variation
in the environment or in the raw materials The
AI can pick up on that So it's not just about
reacting to problems after the fact. It's about
getting ahead of the game, preventing them in
the first place. Right. And there's this other
area, high -content screening. That's where we're
looking at how cells respond to drugs. Very complex
stuff. And they really emphasize the importance
of sophisticated data analysis. That's exactly
where AI shines. Yeah. It's like having this
super smart analyst watching every single aspect
of drug quality. 204 .7 never misses a beat.
Wow. So taking all of this together, all these
amazing new technologies, what kind of impact
are we really talking about here? I mean, is
this just some incremental tweaks, or is this
something that could fundamentally change how
we do pharmaceutical analysis? Oh, I think we're
talking about a complete transformation, a whole
new ballgame. One of the biggest changes is going
to be in terms of cost effectiveness. OK, yeah.
Think about it. Microfluidics, that cuts down
on the reagents you need? Then you've got the
faster analysis times across the board that's
thanks to microfluidics and AI that means lower
labor costs and Portable testing well that could
mean we don't need as much of that big expensive
lab infrastructure And it seems like speed is
a huge factor in all of this. Almost all of these
technologies promise to get us those results
faster. Oh, absolutely. Whether it's those super
fast reactions happening in the microfluidic
systems, or getting instant results with portable
spectroscopy, or AI just crunching through those
huge data sets automatically, all these technologies
can drastically speed up the whole quality control
process. And that's critical. We want to get
those meds to patients as quickly as we can.
And while a lot of our sources focus on point
of need testing within the manufacturing process,
I could see how this could expand further down
the line. Yeah. Maybe even playing a role in
stopping counterfeit drugs, although our sources
don't really get into that specifically. You're
right. That's a really interesting point. Right
now, the main focus seems to be on making things
more efficient, boosting quality within the existing
system. But as these technologies get even better,
there's definitely potential for a wider impact
on drug safety and access. OK, so we've talked
a lot about the possibilities, which are pretty
mind blowing, but we always got to come back
to reality. And our focus today is also on seeing
how these technologies are actually being used
in the real world of pharmaceutical QC. So, based
on what we've read, are companies actually using
these things widely, and what kind of challenges
are they bumping into as they try to scale these
things up? This is where our sources are a little
thin on details. We don't have a ton of specific
case studies that show everyone jumping on board
and using these cutting -edge technologies in
their everyday QC work. We don't have a lot of
info on early successes, the big hurdles they
face trying to scale up, or the big lessons learned
from those early pilot projects. Not in this
specific field, anyway. Interesting. So it seems
like the potential is there, the science is solid,
but actually putting it into practice on a large
scale Maybe that's still in the early stages,
at least based on what we've seen. Yeah, but
we can definitely see the direction things are
moving in. all of our sources really emphasize
the need for solid, reliable analytical methods.
Whether it's proving that different versions
of a drug are equivalent, meticulously tracking
down every single impurity to meet those GMP
regulations, or running those thorough stability
tests to make sure a drug stays safe and effective
for its entire shelf life. I mean, it all points
to this clear need for better analytical tools.
And the fact that people are actively exploring
and even using these technologies in related
fields like diagnostics and drug discovery, that
tells me they're gonna make their way into pharmaceutical
QC too. And I imagine that taking something from
a lab setting where it works great and then scaling
it up to handle the huge volume of work in pharmaceutical
manufacturing, that's got to be a whole other
challenge. It is, absolutely. You're gonna have
to make sure that performance is consistent across
a ton of devices that the tech can meet those
super strict quality standards and regulations
that govern drug production, and you're going
to need people who know how to run and maintain
these advanced systems. Moving from those well
-established methods to these newer approaches,
that's going to take careful planning and a really
deep understanding of how reliable these technologies
are over the long haul in a manufacturing environment.
Okay, so we've covered a lot of ground here.
It seems like the future of pharmaceutical quality
control is really bright with these new technologies
coming onto the scene. I mean, we're talking
about cutting costs, getting results faster,
and even doing quality checks in ways we never
even imagined before. Exactly. And while the
sources we looked at do a great job of explaining
the science behind these technologies and their
potential, we don't have a ton of info on how
widely they're being used in the real world of
pharmaceutical QC. That tells me we're still
in the early stages of this transition, but it's
definitely happening. And that brings us to a
final thought for all of you listening. You know,
with all these advancements in analytical science
happening so fast and the pharmaceutical industry's
commitment to quality and safety, what kind of
unexpected uses or maybe even roadblocks do you
think might pop up as? These technologies become
more and more ingrained in how we do quality
control in the years to come. And how will those
regulatory bodies that oversee this whole industry
adapt? They'll need to find a way to encourage
innovation while making sure patients are safe,
which is always the top priority. You're right.
It's going to be fascinating to see how this
all plays out. It really is. This is where science,
technology, and public health all come together.
And with that, we've reached the end of our deep
dive into this amazing world of emerging technologies
and pharmaceutical quality control. I hope this
conversation has given you some insight into
the future of how we analyze medicines and ensure
their safety and effectiveness. Thanks for tuning
in. Thanks for having me. And we'll see you next
time on the deep dive.